Claris collects $118M to take eye drop into pivotal testing next year
Claris collects $118M to take eye drop into pivotal testing next year.
Claris Bio is a ophthalmology company. See today's news for the latest developments.
Initial profile created
Claris collects $118M to take eye drop into pivotal testing next year.
Novo Holdings-backed Claris Bio emerges with $118M.
Leadership team